The medicinal use of realgar (As4S4) and its recent development as an anticancer agent
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference65 articles.
1. DMPS-arsenic challenge test II. Modulation of arsenic species, including monomethylarsonous acid (MMA(III)), excreted in human urine;Aposhian;Toxicology and Applied Pharmacology,2000
2. Mechanochemical preparation and anticancer effect of realgar As4S4 nanoparticles;Balaz;Materials Letters,2009
3. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of bcl-2 expression and modulation of PML-RAR alpha/PML proteins;Chen;Blood,1996
4. Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment;Cohen;Critical Reviews in Toxicology,2006
5. The reduction of trimethylarsine oxide to trimethylarsine by thiols: a mechanistic model for the biological reduction of arsenicals;Cullen;Journal of Inorganic Biochemistry,1984
Cited by 95 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chemotherapy-free approaches to newly-diagnosed acute promyelocytic leukaemia: is oral-arsenic trioxide/all-trans retinoic acid/ascorbic acid the answer?;Expert Review of Hematology;2024-08-12
2. Data mining of arsenic-based small molecules geometrics present in Cambridge structural database;Chemosphere;2024-07
3. Harness arsenic in medicine: current status of arsenicals and recent advances in drug delivery;Expert Opinion on Drug Delivery;2024-06-02
4. Dissection of scientific compatibility of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia from the perspective of toxicology;Journal of Ethnopharmacology;2023-12
5. Acid ground nano‐realgar processed product inhibits breast cancer by inducing mitophagy via the p53/BNIP3/NIX pathway;Journal of Cellular and Molecular Medicine;2023-08-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3